Georgiamune
Latest round
- Series A
Last raised
- Feb 2023
Total raised
- $68M
Investors
- 7
About Georgiamune
Based in Maryland, US, and founded in 2017 by CEO Samir Khleif, Georgiamune Inc. operates as a biotechnology company providing immunotherapeutic and immune signaling pathways to fight diseases. In August 2023, Georgiamune Inc. Georgiamune Inc. provides medical solutions for cancer, autoimmune, antibody, and small molecules such as GIM-122, GIM-531, GIM-407, GIM-0616, GIM-0915, GIM-0710, GIM-0228, and GIM-1213s. The company provides a platform for supporting patients with cancer and autoimmune diseases. In addition, the firm provides research and development services for preclinical and clinical programs.
Who invested in Georgiamune
7 investors across 3 rounds
See all investors in Georgiamune
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Georgiamune
Who invested in Georgiamune?
Georgiamune has 7 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Georgiamune raised?
Georgiamune has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Georgiamune last raise money?
Georgiamune's most recent round on record is a Series A, in Feb 2023.
What does Georgiamune do?
Based in Maryland, US, and founded in 2017 by CEO Samir Khleif, Georgiamune Inc.
Where is Georgiamune headquartered?
Georgiamune is headquartered in Gaithersburg, US.
Which VCs invest in companies like Georgiamune?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Georgiamune's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Georgiamune? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.